Source: European Neuropsychopharmacology. Conference titles: Congress of European College of Neuropsychopharmacology (ECNP). Unidade: FM
Subjects: PLACEBOS, FÁRMACOS (APLICAÇÕES TERAPÊUTICAS), ESTUDOS RANDOMIZADOS, TRANSTORNO OBSESSIVO-COMPULSIVO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
COSTA, D. L. C. et al. Serotonin reuptake inhibitor augmentation with n-acetylcysteine in treatment resistant ocd: a double-blind randomized controlled trial. European Neuropsychopharmacology. Amsterdam: ECNP. Disponível em: http://www.sciencedirect.com/science/article/pii/S0924977X15307987. Acesso em: 19 nov. 2024. , 2015APA
Costa, D. L. C., Diniz, J. B., Joaquim, M., Acciarito, A. C., Rodrigues, B., Oda, E., et al. (2015). Serotonin reuptake inhibitor augmentation with n-acetylcysteine in treatment resistant ocd: a double-blind randomized controlled trial. European Neuropsychopharmacology. Amsterdam: ECNP. Recuperado de http://www.sciencedirect.com/science/article/pii/S0924977X15307987NLM
Costa DLC, Diniz JB, Joaquim M, Acciarito AC, Rodrigues B, Oda E, Requena G, Miguel EC, Shavitt RG. Serotonin reuptake inhibitor augmentation with n-acetylcysteine in treatment resistant ocd: a double-blind randomized controlled trial [Internet]. European Neuropsychopharmacology. 2015 ; 25( suppl. 2): S570.[citado 2024 nov. 19 ] Available from: http://www.sciencedirect.com/science/article/pii/S0924977X15307987Vancouver
Costa DLC, Diniz JB, Joaquim M, Acciarito AC, Rodrigues B, Oda E, Requena G, Miguel EC, Shavitt RG. Serotonin reuptake inhibitor augmentation with n-acetylcysteine in treatment resistant ocd: a double-blind randomized controlled trial [Internet]. European Neuropsychopharmacology. 2015 ; 25( suppl. 2): S570.[citado 2024 nov. 19 ] Available from: http://www.sciencedirect.com/science/article/pii/S0924977X15307987
